Immunotherapy Drugs Market 2026: Precision Medicine, Next-Generation Biologics And Expanding Cancer Indications Fuel Growth Opportunities

(MENAFN- GlobeNewsWire - Nasdaq) Biotech advances and demand for targeted care are driving immunotherapy, creating opportunities in antibodies, checkpoint inhibitors, personalized medicine and combination therapies.

Dublin, Sept. 15, 2026 (GLOBE NEWSWIRE) -- "Immunotherapy Drugs Market (2026 Edition)" has been added to ResearchAndMarkets.com's offering.

The latest global immunotherapy drugs market report provides a comprehensive analysis of industry trends, growth drivers, market segmentation and regional developments. The study assesses the evolving competitive and clinical landscape while examining the factors influencing demand for innovative immunotherapy drugs across major healthcare markets.

The global immunotherapy drugs market is recording significant growth, supported by continued advances in biotechnology and rising demand for targeted treatment options. Immunotherapy has become an increasingly important treatment modality for cancer, autoimmune and inflammatory diseases, infectious diseases and other complex conditions. Growing clinical adoption and the expansion of approved therapeutic applications are strengthening the market's long-term outlook.

By indication, the report segments the immunotherapy drugs market into cancer, autoimmune and inflammatory diseases, and other indications. Cancer represents a major area of commercial and clinical activity due to the increasing global prevalence of the disease and sustained investment in oncology research. Demand is also rising across autoimmune and inflammatory disease applications as pharmaceutical companies pursue new treatment candidates and broader indications.

Based on drug type, the market is categorized into monoclonal antibodies, immunomodulators and vaccines. Monoclonal antibodies continue to play an influential role in market development, while immunomodulators and vaccines contribute to an increasingly diverse product landscape. The growing adoption of immune checkpoint inhibitors, next-generation biologics and combination therapies is also creating new opportunities for drug developers, biotechnology companies and healthcare providers.

Several factors are accelerating global immunotherapy drugs market growth. These include the increasing burden of cancer and chronic diseases, a robust pipeline of investigational products, greater awareness among patients and healthcare professionals, and rising demand for personalized medicine. Pharmaceutical and biotechnology companies are also expanding research programs focused on improving treatment efficacy, safety and patient outcomes.

The development of combination therapies is expected to remain an important market trend. Researchers and manufacturers are evaluating immunotherapy drugs alongside other treatment modalities to address unmet clinical needs and expand eligible patient populations. At the same time, advances in biomarker research and precision medicine are supporting more focused drug development strategies and treatment selection.

The report evaluates the immunotherapy drugs market across the Americas, Europe, Asia Pacific, and the Middle East and Africa. It also provides country-level analysis for the United States, Canada, Germany, the United Kingdom, France, Italy, Spain, China, Japan and India. This geographic coverage offers insight into regional demand, healthcare investment, research activity and the adoption of advanced therapies.

The Americas remain a key market due to established biotechnology capabilities, substantial healthcare expenditure and strong research and development activity. Europe also represents an important region, supported by advanced healthcare systems and continued pharmaceutical innovation. Asia Pacific is gaining prominence as healthcare access improves, clinical research expands and demand for advanced treatments increases in major markets such as China, Japan and India.

Government agencies, academic institutions, pharmaceutical manufacturers and private investors are increasing funding for immunotherapy research and development. These investments are helping accelerate clinical programs and support the advancement of novel therapies through regulatory review. Continued collaboration among industry stakeholders is expected to reinforce innovation and contribute to future market expansion.

Overall, the global immunotherapy drugs market is positioned for sustained development as scientific innovation, personalized medicine and expanding therapeutic applications reshape treatment strategies. The report offers strategic intelligence for pharmaceutical companies, biotechnology firms, investors, healthcare organizations and other stakeholders seeking to assess emerging opportunities within this dynamic global market.

Key Topics Covered:
1. Market Background
1.1 Scope and Product Outlook
1.2 Executive Summary
1.3 Research Methodology
2. Analyst Recommendations
2.1 Adoption of AI in Drug Discovery
2.2 Combination Therapies
3. Global Immunotherapy Drugs Market: Historic and Forecast
3.1 Impact Analysis of Macro Economic Factors on Global Immunotherapy Drugs Market
3.2 Prevalence of Cancer, WHO regions
3.3 Global autoimmune disorders spending from 2020 to 2023
3.4 Global Immunotherapy Drugs Market: Dashboard
3.5 Global Immunotherapy Drugs Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
3.6 Global Immunotherapy Drugs Market: Market Value Assessment
3.7 Global Immunotherapy Drugs Market Segmentation: By Indication
3.7.1 Global Immunotherapy Drugs Market, By Indication Overview
3.7.2 Global Immunotherapy Drugs Market Attractiveness Index, By Indication
3.7.3 Global Immunotherapy Drugs Market Size, By Cancer, By Value, 2020H-2030F (USD Billion & CAGR)
3.7.4 Global Immunotherapy Drugs Market Size, By Autoimmune & Inflammatory Diseases, By Value, 2020H-2030F (USD Billion & CAGR)
3.7.5 Global Immunotherapy Drugs Market Size, By Other Indications, By Value, 2020H-2030F (USD Billion & CAGR)
3.8 Global Immunotherapy Drugs Market Segmentation: By Drug Type
3.8.1 Global Immunotherapy Drugs Market, By Drug Type Overview
3.8.2 Global Immunotherapy Drugs Market Attractiveness Index, By Drug Type
3.8.3 Global Immunotherapy Drugs Market Size, By Monoclonal Antibodies, By Value, 2020H-2030F (USD Billion & CAGR)
3.8.4 Global Immunotherapy Drugs Market Size, By Immunomodulators, By Value, 2020H-2030F (USD Billion & CAGR)
3.8.5 Global Immunotherapy Drugs Market Size, By Vaccines, By Value, 2020H-2030F (USD Billion & CAGR)
4. Immunotherapy Drugs Market, Region Analysis
4.1 Regional Coverage of the Study
4.2 Regional Snapshot
5. Americas Immunotherapy Drugs Market: Historic and Forecast
5.1 Americas Immunotherapy Drugs Market: Snapshot
5.2 Americas Immunotherapy Drugs Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
5.3 Americas Immunotherapy Drugs Market: Key Factors
5.4 Americas Immunotherapy Drugs Market: Segment Analysis
5.5 Americas Immunotherapy Drugs Market Segmentation: By Indication
5.5.1 Americas Immunotherapy Drugs Market, By Indication Overview
5.5.2 Americas Immunotherapy Drugs Market Size, By Cancer, By Value, 2020H-2030F (USD Billion & CAGR)
5.5.3 Americas Immunotherapy Drugs Market Size, By Autoimmune & Inflammatory Diseases, By Value, 2020H-2030F (USD Billion & CAGR)
5.5.4 Americas Immunotherapy Drugs Market Size, By Other Indications, By Value, 2020H-2030F (USD Billion & CAGR)
5.6 Americas Immunotherapy Drugs Market Segmentation: By Drug Type
5.6.1 Americas Immunotherapy Drugs Market, By Drug Type Overview
5.6.2 Americas Immunotherapy Drugs Market Size, By Monoclonal Antibodies, By Value, 2020H-2030F (USD Billion & CAGR)
5.6.3 Americas Immunotherapy Drugs Market Size, By Immunomodulators, By Value, 2020H-2030F (USD Billion & CAGR)
5.6.4 Americas Immunotherapy Drugs Market Size, By Vaccines, By Value, 2020H-2030F (USD Billion & CAGR)
5.7 Americas Immunotherapy Drugs Market Segmentation: By Country
5.7.1 Americas Immunotherapy Drugs Market, by Country Overview
5.7.2 United States Immunotherapy Drugs Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
5.7.2.1 United States Immunotherapy Drugs Market, By Indication
5.7.2.2 United States Immunotherapy Drugs Market, By Drug Type
5.7.3 Canada Immunotherapy Drugs Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
5.7.3.1 Canada Immunotherapy Drugs Market, By Indication
5.7.3.2 Canada Immunotherapy Drugs Market, By Drug Type
5.7.4 Rest of Americas Immunotherapy Drugs Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
5.7.5.1 Rest of Americas Immunotherapy Drugs Market, By Indication
5.7.5.2 Rest of Americas Immunotherapy Drugs Market, By Drug Type
6. Europe Immunotherapy Drugs Market: Historic and Forecast
6.1 Europe Immunotherapy Drugs Market: Snapshot
6.2 Europe Immunotherapy Drugs Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
6.3 Europe Immunotherapy Drugs Market: Key Factors
6.4 Europe Immunotherapy Drugs Market: Segment Analysis
6.5 Europe Immunotherapy Drugs Market Segmentation: By Indication
6.5.1 Europe Immunotherapy Drugs Market, By Indication Overview
6.5.2 Europe Immunotherapy Drugs Market Size, By Cancer, By Value, 2020H-2030F (USD Billion & CAGR)
6.5.3 Europe Immunotherapy Drugs Market Size, By Autoimmune & Inflammatory Diseases, By Value, 2020H-2030F (USD Billion & CAGR)
6.5.4 Europe Immunotherapy Drugs Market Size, By Other Indications, By Value, 2020H-2030F (USD Billion & CAGR)
6.6 Europe Immunotherapy Drugs Market Segmentation: By Drug Type
6.6.1 Europe Immunotherapy Drugs Market, By Drug Type Overview
6.6.2 Europe Immunotherapy Drugs Market Size, By Monoclonal Antibodies, By Value, 2020H-2030F (USD Billion & CAGR)
6.6.3 Europe Immunotherapy Drugs Market Size, By Immunomodulators, By Value, 2020H-2030F (USD Billion & CAGR)
6.6.4 Europe Immunotherapy Drugs Market Size, By Vaccines, By Value, 2020H-2030F (USD Billion & CAGR)
6.7 Europe Immunotherapy Drugs Market Segmentation: By Country
6.7.1 Europe Immunotherapy Drugs Market, by Country Overview
6.7.2 United Kingdom Immunotherapy Drugs Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
6.7.2.1 United Kingdom Immunotherapy Drugs Market, By Indication
6.7.2.2 United Kingdom Immunotherapy Drugs Market, By Drug Type
6.7.3 Germany Immunotherapy Drugs Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
6.7.3.1 Germany Immunotherapy Drugs Market, By Indication
6.7.3.2 Germany Immunotherapy Drugs Market, By Drug Type
6.7.4 France Immunotherapy Drugs Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
6.7.4.1 France Immunotherapy Drugs Market, By Indication
6.7.4.2 France Immunotherapy Drugs Market, By Drug Type
6.7.5 Italy Immunotherapy Drugs Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
6.7.5.1 Italy Immunotherapy Drugs Market, By Indication
6.7.5.2 Italy Immunotherapy Drugs Market, By Drug Type
6.7.6 Spain Immunotherapy Drugs Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
6.7.6.1 Spain Immunotherapy Drugs Market, By Indication
6.7.6.2 Spain Immunotherapy Drugs Market, By Drug Type
6.7.6 Rest of Europe Immunotherapy Drugs Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
6.7.6.1 Rest of Europe Immunotherapy Drugs Market, By Indication
6.7.6.2 Rest of Europe Immunotherapy Drugs Market, By Drug Type
7. Asia-Pacific Immunotherapy Drugs Market: Historic and Forecast
7.1 Asia-Pacific Immunotherapy Drugs Market: Snapshot
7.2 Asia-Pacific Immunotherapy Drugs Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
7.3 Asia-Pacific Immunotherapy Drugs Market: Key Factors
7.4 Asia-Pacific Immunotherapy Drugs Market: Segment Analysis
7.5 Asia-Pacific Immunotherapy Drugs Market Segmentation: By Indication
7.5.1 Asia-Pacific Immunotherapy Drugs Market, By Indication Overview
7.5.2 Asia-Pacific Immunotherapy Drugs Market Size, By Cancer, By Value, 2020H-2030F (USD Billion & CAGR)
7.5.3 Asia-Pacific Immunotherapy Drugs Market Size, By Autoimmune & Inflammatory Diseases, By Value, 2020H-2030F (USD Billion & CAGR)
7.5.4 Asia-Pacific Immunotherapy Drugs Market Size, By Other Indications, By Value, 2020H-2030F (USD Billion & CAGR)
7.6 Asia-Pacific Immunotherapy Drugs Market Segmentation: By Drug Type
7.6.1 Asia-Pacific Immunotherapy Drugs Market, By Drug Type Overview
7.6.2 Asia-Pacific Immunotherapy Drugs Market Size, By Monoclonal Antibodies, By Value, 2020H-2030F (USD Billion & CAGR)
7.6.3 Asia-Pacific Immunotherapy Drugs Market Size, By Immunomodulators, By Value, 2020H-2030F (USD Billion & CAGR)
7.6.4 Asia-Pacific Immunotherapy Drugs Market Size, By Vaccines, By Value, 2020H-2030F (USD Billion & CAGR)
7.7 Asia-Pacific Immunotherapy Drugs Market Segmentation: By Country
7.7.1 Asia-Pacific Immunotherapy Drugs Market, by Country Overview
7.7.2 China Immunotherapy Drugs Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
7.7.2.1 China Immunotherapy Drugs Market, By Indication
7.7.2.2 China Immunotherapy Drugs Market, By Drug Type
7.7.3 Japan Immunotherapy Drugs Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
7.7.3.1 Japan Immunotherapy Drugs Market, By Indication
7.7.3.2 Japan Immunotherapy Drugs Market, By Drug Type
7.7.4 India Immunotherapy Drugs Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
7.7.4.1 India Immunotherapy Drugs Market, By Indication
7.7.4.2 India Immunotherapy Drugs Market, By Drug Type
7.7.5 Rest of Asia-Pacific Immunotherapy Drugs Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
7.7.5.1 Rest of Asia-Pacific Immunotherapy Drugs Market, By Indication
7.7.5.2 Rest of Asia-Pacific Immunotherapy Drugs Market, By Drug Type
8. Middle East & Africa Immunotherapy Drugs Market: Historic and Forecast
8.1 Middle East & Africa Immunotherapy Drugs Market: Snapshot
8.2 Middle East & Africa Immunotherapy Drugs Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
8.3 Middle East & Africa Immunotherapy Drugs Market: Key Factors
8.4 Middle East and Africa Immunotherapy Drugs Market: Segment Analysis
8.5 Middle East & Africa Immunotherapy Drugs Market Segmentation: By Indication
8.5.1 Middle East & Africa Immunotherapy Drugs Market, By Indication Overview
8.5.2 Middle East & Africa Immunotherapy Drugs Market Size, By Cancer, By Value, 2020H-2030F (USD Billion & CAGR)
8.5.3 Middle East & Africa Immunotherapy Drugs Market Size, By Autoimmune & Inflammatory Diseases, By Value, 2020H-2030F (USD Billion & CAGR)
8.5.4 Middle East & Africa Immunotherapy Drugs Market Size, By Other Indications, By Value, 2020H-2030F (USD Billion & CAGR)
8.6 Middle East & Africa Immunotherapy Drugs Market Segmentation: By Drug Type
8.6.1 Middle East & Africa Immunotherapy Drugs Market, By Drug Type Overview
8.6.2 Middle East & Africa Immunotherapy Drugs Market Size, By Monoclonal Antibodies, By Value, 2020H-2030F (USD Billion & CAGR)
8.6.3 Middle East & Africa Immunotherapy Drugs Market Size, By Immunomodulators, By Value, 2020H-2030F (USD Billion & CAGR)
8.6.4 Middle East & Africa Immunotherapy Drugs Market Size, By Vaccines, By Value, 2020H-2030F (USD Billion & CAGR)
9. Market Dynamics
9.1 Impact assessment of Market Dynamics on Immunotherapy Drugs Market
9.2 Drivers
9.3 Restraints
9.4 Trends
Companies Featured

• F. Hoffmann-La Roche AG
• Merck & Co., Inc.
• Eli Lily & Co.
• Pfizer
• Novartis AG
• Amgen Inc.
• Sanofi
• Johnson & Johnson
• Bayer
• Bristol Myers Squibb

For more information about this report visit

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood,Senior Press Manager... For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

MENAFN15092026004107003653ID1111666675